Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Proposes Criteria To Allow Free Phytosterol CHD Reduction Claim

This article was originally published in The Tan Sheet

Executive Summary

FDA should allow CHD reduction claims for nonesterified phytosterol supplements to that disperse efficiently from tablet form and help block cholesterol uptake, Pfizer argues in comments to the agency.

You may also be interested in...



FDA Extends Enforcement Discretion On Free Phytosterol Health Claims

FDA will give firms a year to relabel or reformulate dietary supplements with nonesterified phytosterols to comply with a proposed rule that overhauls a health claim linking phytosterols to a reduced risk of coronary heart disease.

Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill

Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.

FDA Expands Phytosterol Heart Health Claim In Proposed Rule

FDA significantly overhauls a health claim linking phytosterols to a reduced risk of coronary heart disease, expanding the type of enriched conventional foods and forms of dietary supplements that can make the claim.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel